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ABSTRACT 
Inappropriate uses of antimicrobial drugs have contributed to the development of resistant 
microbial pathogens. This phenomenon requires discovery and development of potential 
antimicrobial compounds from organic materials. Lumbricus rubellus is the ubiquitous 
earthworm containing antimicrobial peptide named Lumbricin-1. The aim of this study was to 
determine the broad spectrum antimicrobial activity of Lumbricus rubellus powder against 
several drug resistant microbes such as Multidrug Resistant (MDR) Pseudomonas aeruginosa, 
Methicillin Resistant Staphylococcus aureus (MRSA) and Fluconazole resistant Candida 
albicans. This experimental study was conducted using Completely Randomized Design 
(CRD) with 6 treatment groups consisting of 100 mg, 200 mg, 300 mg, 400 mg and 500 mg 
L.rubellus powder in 5 ml solvent (acetic acid and acetonitrile) and negative control groups. 
One percent of each concentration then was used in the antimicrobial activity testing using 
Kirby Bauer disc diffusion method. Data of this research were analyzed by ANOVA. The 
results showed that L. rubellus powder in each of the concentrations of 100 mg, 200 mg, 300 
mg, 400 mg and 500 mg obtained an average inhibition zone of 14.33 mm, 14.17 mm, 14.00 
mm, 15.00 mm and 13.00 mm respectively against MDR P. aeruginosa; 16.75 mm, 18.50 mm, 
18.75 mm, 16.75 mm and 17.25 mm against MRSA; 16.50 mm, 18.00 mm, 17.50 mm, 17.75 
mm and 16 mm against Fluconazole resistant C. albicans. Statistical analysis revealed that 
Lumbricus rubellus powder in the tested concentrations showed significant broad spectrum 
antimicrobial activity against drug resistant microbes (p<0.05). 
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Introduction 
Antibiotic resistance against microorganisms is still a major problem in the health sector. 
Resistance to antibiotics is a change in the ability of microorganisms to become resistant to 
antibiotics. This happens due to the changing nature of the microorganisms that can no longer 
be inhibited or killed. The drug will lost its efficacy and its potency will decline and even 
disappear. Microorganisms that are resistant to antibiotics would not be killed by antibiotics, 
then multiply and spread so that it becomes more dangerous (WHO, 2011). Antimicrobial 
therapy is the basis for microbial infection (bacteria and fungi), but the irrational use becomes 
the major factor in the resistance of microorganisms to antimicrobials (Harbottle et al., 2006) 
One of the alternatives to encounter the antimicrobial resistance is to use natural 
materials. The use of these materials, ranging from plants to animals, is increasingly being 
developed by scientists. One of them is earthworm (Lumbricusrubellus) powder. Earthworms 
(L.rubellus) plays an important role in human life because of its high nutrient content, 
especially protein (64-76%) (Palungkun, 1999).  
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Earthworms (L.rubellus) also contain antimicrobial peptide (AMP) named Lumbricin-1 
which serves as a natural defense against microbial pathogens in the environment (Tasiemski, 
2008). This proline-rich peptide is expressed constitutively by adult worm of L. rubellus and 
had shown its broad spectrum antimicrobial peptide against Gram positive and negative 
bacteria and fungi (Cho, et al. 1998). This study aims to determine the broad-spectrum 
antimicrobial activity of L. rubellus earthworm powder against a number of pathogenic 
microbes isolated from clinical samples such as Multidrug Resistant (MDR) Pseudomonas 
aeruginosa, Methicillin Resistant Staphylococcus aureus (MRSA) and fluconazole-resistant 
Candida albicans.  
 
Materials and Methods 
This experimental study was conducted using Completely Randomized Design (CRD) 
with 6 treatment groups consisting of 100 mg, 200 mg, 300 mg, 400 mg and 500 mg L. 
rubellus powder in 5 ml solvent (acetic acid and acetonitrile) and negative control groups, in 
normalized concentration (1%).  
 
Identification of Tested Microbes 
The tested microbes were isolated from various clinical specimens. The MDR P. 
aeruginosa was isolated from the ear swab of middle ear infection patients. The MRSA isolate 
was obtained from the stock culture isolated from the pus of diabetic ulcer patients and 
Fluconazole resistant C. albicans was acquired from the vaginal swab of vaginal candidiasis 
patients at the Zainoel Abidin Hospital.  
Macroscopic, Microscopic and Biochemistry test of Identification. Re-identification of 
the MDR P. aeruginosa was performed using macroscopic (the examination comprised shape, 
surface, border and color of the colony growing in the Nutrient Agarand Soboroud Dextrose 
agar medium), and microscopic tests (Gram Staining). The examination was continued by 
using biochemical identification test using RapID NF Plus (Remel). MethicillinResistant 
Staphylococcus aureus had been identified by using microscopic examination (Gram staining), 
catalase test and coagulation test. Identification of C. albicans was performed by microscopic 
evaluation (Gram staining, 10 % Potassium Hydroxide examination and germ tube test). 
Test of Resistance. Inocula was gradually suspended into sterile NaCl 0.9% on the wall 
of the test tube to produce a fine bacterial suspension. The tested microbes were inoculated to 
an MHA medium by dipping a sterilized cotton bud into the inocula. The cotton bud was 
applied onto the surrounding of the agar surface. The inocula was left to dry for a few minutes 
at room temperature.Resistance test was performed by using oxacillin 5 µg antibiotic disc (for 
MRSA), Ceftazidime 30 µg, Ceftriaxone 30 µg, Ciprofloxacin 5 µg, Gentamicin 10 µg, 
Meropenem 10 µg, Tobramicin 10 µg (for MDR P. aeruginosa) and Nystatin 100 U and 
Fluconazole 25 µg (for C. albicans) which was incubated at 350C. After that, the diameter of 
the formed inhibition zone was measured using a vernier caliper and the result was stated in 
millimeter (mm).  
 
The Formulation of Lumbricus rubellus Powder 
Ten kilograms of L. rubellus were separated from the enlargement media, then washed 
and rinsed thoroughly. Next, L.rubellus was stored in the refrigerator for 24 hours to detach all 
dirt. It was thenwashed again and rinsed clean then crushed to form a paste. The paste was 
heated in the oven at a temperature of 40° C for 48 hours. Dried paste was then pulverized in a 
blender and filtered. The powder was stored in a sealed container. 
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Antibacterial Activity Test of Lumbricus rubellus powder against Drug Resistant Microbes 
The preparation of working solution was based on the peptide dissolution protocol 
(Thinkpeptide, 2012) with modification. 100mg, 200mg, 300mg, 400mgand500mgearthworm 
powder were placed in steriletubesthen added 2 mL of 50% acetic acid. The solution then was 
homogenized by using vortex for 5 minutes. This treatment was repeated twice. Next, 1 mL of 
Acetonitrilewas added to thesolutiontoachieve atotalvolumeof 5mL and again homogenized. 
The earthwormpowdersolution used for antimicrobial activity was that with the concentration 
of 1%. 
The antimicrobial activity test applied the Kirby-Bauer disc diffusion method using 
Mueller Hinton Agar (MHA) medium, in accordance with the procedures of European 
Committee on Antimicrobial Susceptibility Testing/EUCAST (2009). Inocula were suspended 
gradually into the sterile NaCl 0.9% on the wall of the test tube to produce a fine bacterial and 
fungal suspension. The turbidity was measured using spectrophotometer at the wavelength of 
625 nm and absorbency of 0.08-0.1 for P. aeruginosa and S. aureus, and 530 nm and 
absorbency of 0,5-0,6 for C. albicans. The tested microbes were inoculated to a MHA medium 
by dipping a sterilized cotton bud into the inocula. The empty disc were soaked in the 1% 
powder solution of different concentrations for 30 minutes. It was then set on an inoculated 
petri dish using sterilized tweezers. The negative control used an empty disc soaked in sterile 
water. Each treatment was repeated 3 times. The next step was incubation for 24 hours at 370C 
for bacteria and 48 hours for fungi. 
 
Results and Discussion 
Identification result of tested microbes 
Macroscopic examination showed the growth of oval-shaped colonies of 3 mm in size, 
with flat edge and smooth surface. The nutrient agar medium turned into green color. The 
result of Gram staining indicated Gram negative bacilli. The RapID NF-Plus test showed 
biochemistry characterization of P. aeruginosa. The resistance test indicated the bacterial 
resistance to more than 2 groups of selected antibiotics which refered to MDR (CLSI, 2012).  
The result of macroscopic observation on the Nutrient Agar (NA) medium showed that S. 
aureus formed a colony of 0.5 mm in size, of white color, round shape with fine border and 
even surface. Gram staining result showed a bacterium in coccus shape, purple color, and 
forming a small group resembling grapes which indicated Gram positive bacterium. The 
coagulation test using plasma in tubes produced a positive result namely the forming of plasma 
coagulation. From the catalase test, a positive result was obtained which was indicated by the 
forming of gas bubbles. The result of resistance test of S. aureus to methicillin showed that S. 
aureus isolates are resistant to antibiotic methicillin (Brown, et al, 2005; CLSI, 2012).  
 Macroscopic examination in Soboroud dextrose agar medium showed the growth of C. 
albicans as smoot or soft colonies of cream coloured, round shape and produced yeast-smell 
like. The result of Gram staining showed Gram positive coloured of micelium and yeast cells. 
The true hyphae was showed  in germ tube test. All the above mentioned results show that the 
tested fungi was C. albicans. The resistance test indicated the resistance to antifungal Nystatin 
and Fluconazole (CLSI, 2012). 
 
Result of Antimicrobial Activity Test of Lumbricus rubellus Powder against Drug 
Resistant Microbes 
The antimicrobial test of L. rubellus powder against the growth of drug resistant 
microbes at the 100 mg/5 ml, 200 g/ml, 300 mg/5ml, 400 mg/ml and 500 mg/ml concentrations 
resulted in inhibition zones of average diameter of 14.33 mm, 14.17 mm, 14.00 mm, 15.00 mm 
and 13.00 mm respectively against MDR P. aeruginosa; 16.75 mm, 18.50 mm, 18.75 mm, 
16.75 mm and 17.25 mm against MRSA; 16.50 mm, 18.00 mm, 17.50 mm, 17.75 mm and 16 
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mm against Fluconazole resistant C. albicans. The data obtained was then analyzed using 
Analysis of Variance (ANOVA) to examine the impact of each treatment. The result of 
ANOVA revealed that there was a significant difference in the antibacterial activity indicated 
by each concentration of  L. rubellus powder. Statistical test was then continued with 
Duncan Test at p<0,05.  
 
Table 1. Average diameter of inhibition zone ± deviation standard of L. rubellus powder 
against the growth of MDR P. aeruginosa. The average value of inhibition zone was followed 
by different superscripts showing significant differences (P<0,05) 
Treatment Diameter of inhibition zone in 
each repetition (mm) 
Average diameter of 
inhibition zone (mm) 
± SD I II III IV 
Negative control 0 0 0 0 0± 0,00a 
100 mg/5 ml 13 15 15 14,3 14,33b ± 1,15 
200 mg/5 ml 14,5 14 14 14,18 14,16b ± 0,27 
300 mg/5 ml 14 13 15 14 14,00b ± 1,00 
400 mg/5 ml 15 16 14 15 15,00b ± 1,00 
500 mg/5 ml 13 13 14,5 13,5 13,5b ± 0,87 
 
 
Table 2. Average diameter of inhibition zone ± deviation standard of L. rubellus powder 
against the growth of MRSA.The average value of inhibition zone was followed by different 
superscripts showing significant differences (P<0.05) 
Treatment Diameter of inhibition zone in 
each repetition (mm) 
Average diameter of 
inhibition zone (mm) 
± SD I II III IV 
Negative control 0 0 0 0 0± 0,00a 
100 mg/5 ml 14 17 18 18 16,75b ± 1,8 
200 mg/5 ml 15 20 19 20 18,50e ± 2,3 
300 mg/5 ml 16 21 18 20 18,75e ± 2,2 
400 mg/5 ml 12 19 17 19 16,75c ± 3,3 
500 mg/5 ml 14 19 18 18 17,25d ± 2,2 
 
Table 3. Average diameter of inhibition zone ± deviation standard of L. rubellus powder 
against the growth of Fluconazole-resistant C. albicans.The average value of inhibition zone 
was followed by different superscripts showing significant differences (P<0.05) 
Treatment Diameter of inhibition zone in 
each repetition (mm) 
Average diameter of 
inhibition zone (mm) 
± SD I II III IV 
Negative control 0 0 0 0 0± 0,00a 
100 mg/5 ml 17 19 15 15 16,5b ± 1,91 
200 mg/5 ml 17 20 17 18 18,0b ± 1,41 
300 mg/5 ml 16 20 16 18 17,5b ± 1,91 
400 mg/5 ml 19 17 18 18 17,7b ± 0,95 
500 mg/5 ml 16 16 15 17 16,0b ± 0,81 
 
The presence of inhibition zones showed that earthworm powder L.rubellus at any tested 
concentration obtained antimicrobial activity against MDR P. aeruginosa, MRSA and 
Fluconazole resistant-C. albicans. Study performed by Cho, et al, showed that L. rubellus 
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contain antimicrobial peptide named Lumbricin-1, which was able to inhibit the growth of 
Gram positive and Gram negative bacteria as well as fungi. 
Living organisms use antimicrobial peptides as one of the major defense against 
microbial infection in their environment. Lumbricin-1 isolated from L. rubellus (sized 7231 
Da, formed by 62 amino acids) is known as proline rich-antimicrobial peptides with broad 
spectrum antimicrobial activity (Cho, et al 1998). Proline form an unique conformational 
structure on the peptide chain and affect the secondary structure then define the mechanism of 
action. In addition to Lumbricin-1, there are other several antimicrobial peptides which are also 
proline rich such as apidaecins, drosocin, metchikowin, bactenecins and PR-39.  
Each antimicrobial perform varied mechanism of action in inhibiting pathogenic 
microorganisms. Gram negative bacteria are able to be inhibited by apidaecins, bactenecins and 
PR-39, while drosocin is able to inhibit both Gram positive and Gram negative, but it cannot 
inhibit the growth of fungi. Gram positive bacteria and fungi can be inhibited by metchikowin, 
but this microbial peptide has no effect on Gram-negative bacteria. The mechanism of action of 
Lumbricin-1 is still unclear but one hypothesis states that it demonstrates a different 
mechanism from other proline-rich antimicrobial peptides. (Cho, et al 1998).  
Mechanism of action of antimicrobial peptide begins with the initial interaction between 
the peptide and the target cell (bacteria or fungi) due to the influence of electrostatic power 
(Yeaman and Yount, 2003). The level of positive charge (cationicity) plays an important factor 
for initial electrostatic interaction between antimicrobial peptide and the negatively charged 
phospholipid membrane of bacteria. The interaction of cations (antimicrobial peptide) and 
anions (bacteria and fungi cell surface) is alleged to cause changes in the permeability of the 
cell membrane so that lumbricin-1 can penetrate into the cytoplasmic membrane and cause cell 
damage (Epand and Vogel, 1999; Jenssen, Pamela and Robert, 2006). There is a strong 
relationship between the levels of antimicrobial peptide cationicity with antimicrobial activity. 
The higher cationicity the stronger antimicrobial activity (Yeaman and Yount, 2003).  
Lumbricin-1 also has a unique hydrophobic surface feature formed by hydrophobic 
amino acids. Lipid bilayer on bacterial cell membrane has both hydrophilic and hydrophobic 
surfaces. In this antimicrobial mechanism, the hydrophobic surface of the peptide interacts with 
the hydrophilic surface of the cell membrane which consequently increases cell membrane 
permeability and lumbricin-1 can enter the hydrophilic lipid layer. Furthermore, when entering 
the hydrophobic layer, allegedly lumbricin-1 has the ability to adjust its shape with the surface 
of the cell membrane. Therefore, the membrane is unable to distinguish foreign peptides which 
causes intracellular instability and growth inhibition (Pasupuleti, 2009). 
Candida albicans has hydrophobic cell wall. It expresses the cell surface hydrophobicity 
(CSH) which is more virulent compared to cell surface hydrophilicity. Hydrophobic surface 
plays an important role in attachment to the host's cell, defense against phagocytosis and 
protection on germination period (Hazen et al, 2001). Hydrophobicity surface is one of the 
virulent factors in C. albicans and it becomes the main target of Lumbricin-1. Lumbricin-1 as 
antimicrobial peptides has the basic ability to adapt to the structure of the hydrophobic amino 
acids (Zasloff, 2002). Lumbricin-1 can form a specific secondary structure and hydrophobic 
surface molecules (Cho et al, 1998). The presence of negative charge on the cell wall of C. 
albicans in addition to hydrophobicity allowed greater interaction with antimicrobial peptides 
(Zasloff, 2002). The broad spectrum antimicrobial activity demonstrated by L. rubellus powder 
indicates that antimicrobial peptide Lumbricin-1 isolated from this organism can be potentially 
developed as a potent antimicrobial agent. 
The presence of Lumbricin-1 in L. rubellus powder should be confirmed by using Tricine 
SDS-PAGE. This important step could not be performed due to unavailability of Tricine. 
 
 
Proceedings of  The 4th Annual International Conference Syiah Kuala University (AIC Unsyiah) 2014 
In conjunction with The 9th Annual International Workshop and Expo on Sumatra Tsunami Disaster and Recovery – AIWEST-DR 2014 
October 22-24, 2014, Banda Aceh, Indonesia 
 
118 
 
Conclusions 
The L. rubellus powder at any tested concentration showed broad spectrum antimicrobial 
activity against MDR P. aeruginosa, MRSA and Fluconazole-resistant C. albicans. The 
antimicrobial activity muncul diduga akibat adanya antimicrobial peptide Lumbricin-1. 
Furthermore, based on the results of this study, earthworm antimicrobial peptide Lumbricin-1 
can be developed as a promising antimicrobial agent. 
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